• Profile
Close

Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: Frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma

Modern Pathology Jan 12, 2020

Shamir ER, et al. - Because pleomorphic (PLCIS) and florid (FLCIS) lobular carcinoma in situ are rare histologic variants of LCIS that are recognized as more aggressive than classic LCIS (CLCIS), but optimal treatment is controversial, experts sought to characterize the genetic drivers of these lesions and their clonal relationships to paired CLCIS and ILC. They utilized capture-based next-generation sequencing to profile 16 LCIS variants, involving paired synchronous ILC and CLCIS in 11 and nine cases, respectively. Recurrent pathogenic alterations involved CDH1, PIK3CA, ERBB2, ERBB3, FOXA1, TP53, and CCND1. Contrasted with ILC in the Cancer Genome Atlas (TCGA), PLCIS, FLCIS, and correlated ILC were enriched for ERBB2 mutations, and PLCIS was enriched for TP53 and FOXA1 mutations. Increased mean nonsynonymous mutations and additional pathogenic alterations and/or CNA in 80%, correlated with CLCIS to PLCIS progression. The outcomes highlight clonal relationships among PLCIS/FLCIS and CLCIS and implicate PLCIS as a genetically advanced ILC precursor. Frequent ERBB2/ERBB3 alterations in PLCIS and FLCIS were consistent with more aggressive behavior and might have predictive and therapeutic implications.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay